DIVY

MELBOURNE: Shares in hearing-aid company Cochlear hit an all-time high of $257.76 around ... read more

MELBOURNE: Drug developer Telix is banking on its flagship prostate cancer imaging product ... read more

MELBOURNE: Cochlear investors will see full-year dividends jump close to 60 per cent ... read more

SYDNEY: Stockland said a booming residential market will help it boost earnings at ... read more